Half-yearly report on CARMAT's liquidity contract

On July 1, 2025, CARMAT published its half-yearly balance sheet regarding the liquidity agreement with the Gilbert Dupont brokerage firm. As of June 30, 2025, the liquidity account held 29,188 shares, with a cash balance of €22,007.31. During the first half of the year, 342,412 shares were purchased for €301,218.05, while 334,515 shares were sold for €298,103.94, spread over 2,275 and 2,260 transactions respectively.

Compared to December 31, 2024, the liquidity account then showed 21,291 shares and a balance of €25,119.99. CARMAT, specialized in the development of the Aeson® artificial heart, indicates that it faces a high risk of default following a receivership procedure initiated on July 1, 2025.